Therapy looks best yet to tackle brain disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
White, A. R. et al. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature, 422, 80 - 83, (2003).
Andrews, N. J. et al. Deaths from variant Creutzfeld-Jakob disease in the UK. Lancet, 361, 751 - 752, (2003).
Ghani, A. C., Ferguson, N. M., Donnelly, C. A & Anderson, R. M. Factors determining the pattern of the variant Creutzfeldt-Jakob disease (vCJD) epidemic in the UK. Proceedings of the Royal Society B, published online, doi:10.1098/rspb.2002.2313 (2003).
Additional information
University of Toronto
Related links
Rights and permissions
About this article
Cite this article
Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature (2003). https://doi.org/10.1038/news030303-7
Published:
DOI: https://doi.org/10.1038/news030303-7